HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
403.96
-3.32 (-0.82%)
Aug 29, 2025, 4:00 PM - Market closed
HCA Healthcare Stock Forecast
Stock Price Forecast
The 13 analysts that cover HCA Healthcare stock have a consensus rating of "Buy" and an average price target of $404.46, which forecasts a 0.12% increase in the stock price over the next year. The lowest target is $370 and the highest is $444.
Price Target: $404.46 (+0.12%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 2 | 2 |
| Buy | 7 | 6 | 6 | 6 | 6 | 6 |
| Hold | 4 | 6 | 7 | 6 | 8 | 8 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 17 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $444 | Buy | Reiterates | $444 | +9.91% | Aug 26, 2025 |
| Baird | Baird | Hold Maintains $380 → $423 | Hold | Maintains | $380 → $423 | +4.71% | Aug 14, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $385 → $375 | Hold | Maintains | $385 → $375 | -7.17% | Aug 14, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $360 → $370 | Hold | Maintains | $360 → $370 | -8.41% | Aug 4, 2025 |
| Barclays | Barclays | Buy Maintains $416 → $390 | Buy | Maintains | $416 → $390 | -3.46% | Jul 28, 2025 |
Financial Forecast
Revenue This Year
75.72B
from 70.60B
Increased by 7.25%
Revenue Next Year
79.22B
from 75.72B
Increased by 4.62%
EPS This Year
26.57
from 22.00
Increased by 20.76%
EPS Next Year
28.72
from 26.57
Increased by 8.11%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 79.6B | 84.6B | |||
| Avg | 75.7B | 79.2B | |||
| Low | 73.0B | 74.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.7% | 11.8% | |||
| Avg | 7.2% | 4.6% | |||
| Low | 3.4% | -1.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 28.26 | 31.02 | |||
| Avg | 26.57 | 28.72 | |||
| Low | 25.09 | 25.92 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 28.4% | 16.7% | |||
| Avg | 20.8% | 8.1% | |||
| Low | 14.0% | -2.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.